The drug testing market involves the detection of one or more illegal and prescribed drugs in the human body samples such as urine, blood, hair, and oral fluids for medicolegal and medical purposes. Drug testing is mainly used to identify the recently used drugs, to find potential abuse or misuse, and to assist in diagnosis or treatment for substance abuse disorder. The commonly tested drug classes include amphetamines, barbiturates, benzodiazepines, cocaine metabolite, marijuana metabolite, methadone, opiates, and phencyclidine. The procedures depend on the type of drug being tested and associated metabolites. Immunoassays and chromatography are the most prominently used techniques in the drug testing market.

The global drug testing market is estimated to be valued at USD 14.32 Bn in 2024 and is expected to reach USD 20.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5% from 2024 to 2031.

Key Takeaways

Key players operating in the drug testing market are Abbott Laboratories, Thermo Fisher Scientific Inc., Quest Diagnostics, LabCorp, Roche Diagnostics, Bio-Rad Laboratories, Siemens Healthineers, Mayo Clinic Laboratories, Medtox Scientific, Inc., Premier Biotech, Express Diagnostics International, Inc., Omega Laboratories, Psychemedics Corporation, and Zywave Inc. The key players are focusing on new product launches, expanding their global footprint, and collaborations with market stakeholders to strengthen their position in the drug testing market.

The Drug Testing Market Demand to the increasing substance abuse cases worldwide and the implementation of stringent laws mandating drug screening at workplaces to ensure public safety. As per the United Nations Office on Drugs and Crime, around 270 million people globally used drugs at least once in 2020.

 Get More Insights on- Drug Testing Market